Beta Drugs Limited has informed the Exchange about Schedule of meet
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beta Drugs Limited has informed the exchange that its management will host an earnings conference call on Friday, 7th November 2025 at 2:00 PM IST to discuss operational and financial performance for the first half of FY26. The call will be led by Chairman & Managing Director Rahul Batra, CFO Nipun Arora, and Director (Sales & Marketing) Ashutosh Shukla, and is being arranged by PhillipCapital (India) Private Limited. The company is listed on the NSE-SME platform under the symbol BETA. Retail investors can pre-register via DiamondPass or dial in using the provided domestic and toll-free international numbers.
This is a routine disclosure announcing the date of the upcoming H1 FY26 earnings call, which will provide investors with details on the company's half-yearly performance. No immediate impact on share price is expected from this notice alone, but it signals that H1 results and management commentary will be shared in the coming week.